Study Links Type 2 Diabetes to Higher Risk of Hearing Loss

Health & LifestyleNews
47

Listen to article (english)

Translate to Spanish or other 102 languages!

A recent review highlights hearing loss as a hidden, yet common, complication of diabetes. Image for illustration purposes.
A recent review highlights hearing loss as a hidden, yet common, complication of diabetes. Image for illustration purposes. 

Mega Doctor News

- Advertisement -

Medical News Today

Diabetes is well known to increase the risk of complications throughout the body, potentially affecting the eyes, kidneys, and nerves. 

As a result, people with diabetes are routinely monitored for conditions such as diabetic retinopathy, kidney disease, and neuropathy. This ongoing care can help prevent severe problems, such as sight loss, kidney damage, and nerve damage.

- Advertisement -

Follow the link below to Medical Nesw Today to read the full story:

https://www.medicalnewstoday.com/articles/1-in-4-adults-type-2-diabetes-experience-hearing-loss?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2026-07-10&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
STHS GME Consortium Welcomes Incoming Class of 65 Medical Residents
Next article
The Truth About Hot Dogs and Your Health

More Articles

How Dogs Benefit Mind and Soul

"Dogs are wonderful greeters. They're waiting for you to come home, and they're always happy to see you. In turn, this increases our feel-good hormones, like dopamine and serotonin,” explained Chivonna Childs, PhD.

Data Reveals US Illicit Fentanyl Use is Double That of Clinical Care

The largest study to date that quantifies and compares medical and illegal use of fentanyl in the United States suggests that illicit use is more than twice as common as medically based use. 

7 Crucial Caregiving Truths Families Often Overlook

If you clicked to read this story, or someone sent it to you, congratulations: You’re a caregiver.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -